Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Petrasch, C; Udovica, S; Witte, F; Liegl-Atzwanger, B; Pokieser, W; Mirzaei, S; Hilbe, W; Kaufmann-Keck, A.
Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy-a case report
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00880-7
Web of Science
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Liegl-Atzwanger Bernadette
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A 68-year-old man was diagnosed with a SMARCA4-deficient thoracic sarcomatoid tumor. Immunochemotherapy with carboplatin, paclitaxel, and pembrolizumab followed by maintenance therapy with pembrolizumab resulted in clinically meaningful remission.
- Find related publications in this database (Keywords)
-
SMARCA4
-
SMARCA2
-
Immunotherapy
-
Chemotherapy
-
Radiotherapy